{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:01:22Z","timestamp":1778050882689,"version":"3.51.4"},"reference-count":45,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Community\u2019s Seventh Framework Programme","award":["602391"],"award-info":[{"award-number":["602391"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Autism spectrum disorder (ASD) is highly prevalent in subjects with Tuberous Sclerosis Complex (TSC), but we are not still able to reliably predict which infants will develop ASD. This study aimed to identify the early clinical markers of ASD and\/or developmental delay (DD) in infants with an early diagnosis of TSC. We prospectively evaluated 82 infants with TSC (6\u201324 months of age), using a detailed neuropsychological assessment (Bayley Scales of Infant Development\u2014BSID, and Autism Diagnostic Observation Schedule\u2014ADOS), in the context of the EPISTOP (Long-term, prospective study evaluating clinical and molecular biomarkers of EPIleptogenesiS in a genetic model of epilepsy\u2014Tuberous SclerOsis ComPlex) project (NCT02098759). Normal cognitive developmental quotient at 12 months excluded subsequent ASD (negative predictive value 100%). The total score of ADOS at 12 months clearly differentiated children with a future diagnosis of ASD from children without (p = 0.012). Atypical socio-communication behaviors (p &lt; 0.001) were more frequently observed than stereotyped\/repetitive behaviors in children with ASD at 24 months. The combined use of BSID and ADOS can reliably identify infants with TSC with a higher risk for ASD at age 6\u201312 months, allowing for clinicians to target the earliest symptoms of abnormal neurodevelopment with tailored intervention strategies.<\/jats:p>","DOI":"10.3390\/jcm8060788","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T11:31:01Z","timestamp":1559561461000},"page":"788","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-060X","authenticated-orcid":false,"given":"Romina","family":"Moavero","sequence":"first","affiliation":[{"name":"Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Via Montpellier 1, 00133 Rome, Italy"},{"name":"Child Neurology Unit, Neuroscience and Neurorehabilitation Department, \u201cBambino Ges\u00f9\u201d Children\u2019s Hospital, IRCCS, P.zza S. Onofrio 4, 00165 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Benvenuto","sequence":"additional","affiliation":[{"name":"Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Via Montpellier 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Emberti Gialloreti","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Siracusano","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy"},{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kotulska","sequence":"additional","affiliation":[{"name":"Department of Neurology and Epileptology, The Children\u2019s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Weschke","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, Charit\u00e9 University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Riney","sequence":"additional","affiliation":[{"name":"Neuroscience Unit, Queensland Children\u2019s Hospital, 501 Stanley Street, South Brisbane, QLD 4101, Australia"},{"name":"School of Clinical Medicine, University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, Brain Center, University Medical Center Utrecht, 3584 Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Feucht","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Krsek","sequence":"additional","affiliation":[{"name":"Motol University Hospital, Charles University, 150 06 Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Necker- Enfants Malades Hospital, University Paris Descartes, Imagine Institute, 75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-2824","authenticated-orcid":false,"given":"Anna","family":"Jansen","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Unit-UZ Brussel, 1050 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Wojdan","sequence":"additional","affiliation":[{"name":"Warsaw University of Technology, Institute of Heat Engineering, 00-661 Warsaw, Poland"},{"name":"Transition Technologies, ul. Pawia 5, 01-030 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julita","family":"Borkowska","sequence":"additional","affiliation":[{"name":"Department of Neurology and Epileptology, The Children\u2019s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzystof","family":"Sadowski","sequence":"additional","affiliation":[{"name":"Department of Neurology and Epileptology, The Children\u2019s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hertzberg","sequence":"additional","affiliation":[{"name":"Diagnose und Behandlungszentrum f\u00fcr Kinder und Jugendliche, Vivantes Klinikum Neuk\u00f6ln, 12351 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Hulshof","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, Brain Center, University Medical Center Utrecht, 3584 Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Samueli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora","family":"Benova","sequence":"additional","affiliation":[{"name":"Motol University Hospital, Charles University, 150 06 Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Department of (Neuro)Pathology, Amsterdam Neuroscience, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands"},{"name":"Stichting Epilepsie Instellingen Nederland (SEIN), The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kwiatkowski","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[{"name":"Department of Development and Regeneration-Section Pediatric Neurology, University Hospitals KU Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3350-6326","authenticated-orcid":false,"given":"Sergiusz","family":"Jozwiak","sequence":"additional","affiliation":[{"name":"Department of Neurology and Epileptology, The Children\u2019s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland"},{"name":"Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland Zwirki i Wigury 63A, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[{"name":"Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Via Montpellier 1, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the EPISTOP Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"Shiell","year":"1998","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"(1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75, 1305\u20131315.","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"Hermans","year":"1997","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"ref_6","first-page":"1236","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"57","author":"Major","year":"2010","journal-title":"Epilepsia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yebeh.2016.04.026","article-title":"White matter disruption is associated with persistent seizures in tuberous sclerosis complex","volume":"60","author":"Moavero","year":"2016","journal-title":"Epilepsy Behav."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1528-1167.2010.02892.x","article-title":"Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex","volume":"52","author":"Kaczorowska","year":"2011","journal-title":"Epilepsia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpn.2015.12.005","article-title":"Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC","volume":"20","author":"Curatolo","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_11","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorder, CBS Publisher & Distribution. [5th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1007\/s10803-014-2202-y","article-title":"Autism treatment in the first year of life: A pilot study of infant start, a parent-implemented intervention for symptomatic infants","volume":"44","author":"Rogers","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s11689-016-9139-8","article-title":"Reduced engagement with social stimuli in 6-month-old infants with later autism spectrum disorder: A longitudinal prospective study of infants at high familial risk","volume":"8","author":"Jones","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.0000000000000568","article-title":"Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex","volume":"83","author":"Jeste","year":"2014","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/jir.12498","article-title":"Early gesture use in fragile X syndrome","volume":"62","author":"Rague","year":"2018","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0883073807309788","article-title":"Characterization of autism in young children with tuberous sclerosis complex","volume":"23","author":"Jeste","year":"2008","journal-title":"J. Child Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/YCO.0000000000000136","article-title":"Advances in the treatment of tuberous sclerosis complex","volume":"28","author":"Leclezio","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ajmg.c.31637","article-title":"A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)","volume":"178","author":"Wilde","year":"2018","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","article-title":"Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex","volume":"76","author":"Numis","year":"2011","journal-title":"Neurology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejpn.2009.03.003","article-title":"Early control of seizures improves long-term outcome in children with tuberous sclerosis complex","volume":"14","author":"Bombardieri","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.yebeh.2011.08.037","article-title":"Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis","volume":"22","author":"Cusmai","year":"2011","journal-title":"Epilepsy Behav."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"Jozwiak","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ejpn.2018.08.005","article-title":"Diagnosis of tuberous sclerosis complex in the fetus","volume":"22","author":"Dragoumi","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpn.2007.06.006","article-title":"Prenatal diagnosis of cerebral lesions in Tuberous sclerosis complex (TSC). Case report and review of the literature","volume":"12","author":"Wortmann","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2017.06.010","article-title":"Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex","volume":"75","author":"Capal","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/aur.1846","article-title":"Early autism symptoms in infants with tuberous sclerosis complex","volume":"10","author":"McDonald","year":"2017","journal-title":"Autism Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/cdev.12262","article-title":"Limited fine motor and grasping skills in 6-month-old infants at high risk for autism","volume":"85","author":"Libertus","year":"2014","journal-title":"Child Dev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s11689-018-9231-3","article-title":"Development of fine motor skills is associated with expressive language outcomes in infants at high and low risk for autism spectrum disorder","volume":"10","author":"Choi","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"ref_31","first-page":"280813","article-title":"Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome","volume":"2012","author":"Winarni","year":"2012","journal-title":"Case Rep. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/aur.1754","article-title":"Parent-delivered early intervention in infants at risk for ASD: Effects on electrophysiological and habituation measures of social attention","volume":"10","author":"Jones","year":"2017","journal-title":"Autism Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Emberti Gialloreti, L., Mazzone, L., Benvenuto, A., Fasano, A., Alcon, A.G., Kraneveld, A., Moavero, R., Raz, R., Riccio, M.P., and Siracusano, M. (2019). Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations. J. Clin. Med., 8.","DOI":"10.3390\/jcm8020217"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0883073810361789","article-title":"Autism spectrum disorders in tuberous sclerosis: Pathogenetic pathways and implications for treatment","volume":"25","author":"Curatolo","year":"2010","journal-title":"J. Child Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Nolan, S.O., Jefferson, T.S., Reynolds, C.D., Smith, G.D., Holley, A.J., Hodges, S.L., and Lugo, J.N. (2019). Neuronal deletion of Pten results in cerebellar motor learning dysfunction and alterations in intracellular signaling. CNS Neurol. Disord. Drug Targets, 30.","DOI":"10.2174\/1871527318666190312122753"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Magdalon, J., Sanchez-Sanchez, S.M., Griesi-Oliveira, K., and Sertie, A.L. (2017). Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030659"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41398-018-0335-z","article-title":"Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism","volume":"9","author":"Rosina","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ncomms2295","article-title":"Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex","volume":"3","author":"Sato","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature11310","article-title":"Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice","volume":"488","author":"Tsai","year":"2012","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00406-016-0703-8","article-title":"mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus","volume":"267","author":"Schneider","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13229-017-0151-y","article-title":"A brain proteomic investigation of rapamycin effects in the Tsc1(+\/\u2212) mouse model","volume":"8","author":"Wesseling","year":"2017","journal-title":"Mol. Autism"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/cap.2016.0100","article-title":"Beneficial Effects of Everolimus on Autism and Attention-Deficit\/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex","volume":"27","author":"Kilincaslan","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: Post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.braindev.2018.07.003","article-title":"Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan","volume":"41","author":"Mizuguchi","year":"2019","journal-title":"Brain Dev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/6\/788\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:55:49Z","timestamp":1760187349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/6\/788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["jcm8060788"],"URL":"https:\/\/doi.org\/10.3390\/jcm8060788","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]}}}